Discontinued — last reported Q3 '25

Business Segments · Exit and other-related costs

Prescription Technology Solutions — Exit and other-related costs

This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ3 2019
Last reportedQ3 2025

How to read this metric

Higher costs indicate significant strategic shifts or business unit rationalization, whereas lower costs suggest operational continuity.

Detailed definition

Captures expenses associated with exiting specific business activities, facilities, or product lines within the Prescrip...

Peer comparison

Comparable to 'exit costs' or 'discontinued operations expenses' found in the segment reporting of large healthcare service providers.

Metric ID: mck_segment_prescription_technology_solutions_exit_and_other_related_costs

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q2 '25Q3 '25
Value$1.00M$1.00M$0.00$0.00$2.00M$1.00M$1.00M$1.00M$2.00M$3.00M$1.00M$8.00M$3.00M$0.00$0.00$0.00$0.00
QoQ Change+0.0%-100.0%-50.0%+0.0%+0.0%+100.0%+50.0%-66.7%+700.0%-62.5%-100.0%
YoY Change+100.0%+0.0%+0.0%+200.0%+0.0%+700.0%+50.0%-100.0%-100.0%-100.0%
Range$0.00$8.00M
CAGR-100.0%
Avg YoY Growth+75.0%
Median YoY Growth+0.0%

Frequently Asked Questions

What is McKesson's prescription technology solutions — exit and other-related costs?
McKesson (MCK) reported prescription technology solutions — exit and other-related costs of $0.00 in Q3 2025.
What does prescription technology solutions — exit and other-related costs mean?
Costs incurred from exiting specific business operations or facilities within the technology solutions segment.